The cervical cancer screening is an integral part of women’s healthcare in the current market. The global cervical cancer diagnostic testing market has been witnessing continuous technological innovations and developments over the years. The global cervical cancer diagnostic testing market is growing at a steady rate and is projected to grow at a CAGR of 6.90%, during the forecast period.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Cervical cancer: An overview

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by test type

Pap smear test

HPV testing

Global cervical cancer Pap smear test market

Global cervical cancer HPV testing market

PART 07: Market segmentation by technology

ELISA

FISH

NASBA

PCR

Multichromatic staining and microscopy

PART 08: Market segmentation by method

Cytopathological method

Molecular method

PART 09: Market segmentation by end-user

Hospitals

Clinical diagnostic laboratories

Homecare

Others

PART 10: Geographical segmentation

Cervical cancer diagnostic testing market in Americas

Cervical cancer diagnostic testing market in EMEA

Cervical cancer diagnostic testing market in APAC

PART 11: Buying criteria

PART 12: Market drivers

Rising prevalence of cervical cancer risk factors

Growing adoption of HPV testing

Reimbursement policies

Increasing global activities by public organizations

PART 13: Impact of drivers

PART 14: Market challenges

Rising awareness toward cervical cancer overscreening

Less public awareness and presence of social barriers

perform HPV tests at home and iring

Limited number of health clinics in developing

countries

Availability of visual inspection methods

PART 15: Impact of drivers and challenges

PART 16: Market trends

Development of new diagnostic platforms

Expansion into emerging markets

Emergence of novel biomarkers

Rise in use of HPV home-testing kits

PART 17: Vendor landscape

Competitive scenario

Geographical presence of key vendors

Key news

PART 18: Key vendor analysis

Abbott Molecular

Becton, Dickinson & Company (BD)

Hologic

QIAGEN

Quest Diagnostics

Roche Molecular Diagnostics

Other prominent vendors

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio